Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Heart. 2018 Sep 18;104(24):1995–2002. doi: 10.1136/heartjnl-2018-313726

Figure 1.

Figure 1

Estimated incidence of various cardiovascular toxicities associated with TKI therapy. [2]–[5], [9] LVSD – Left ventricular systolic dysfunction; MI – Myocardial infarction